Investor Relations

We are an innovative and dynamic company marketing products developed based on scientific evidence for diagnosis and therapy in the indications autoimmune diseases, chronobiology and women’s health.

We have raised more than five million euros in capital and funding since our establishment in 2011.

February 2014 saw VivoSensMedical launch a successful crowdfunding campaign on the Seedmatch online platform as first med-tech company to take this approach.

Interested in investing in a dynamic and innovative company that draws on more than forty years of scientific experience and reputation as well as over half a century of management expertise? If so, we look forward to hearing from you.

Individual diagnostics for better therapies